Companies: 10,795·Total market cap: $144.5T
NewCardio, Inc.

NewCardio, Inc.

NWCIOTCHealthcare● Active
$0.00
$-0.00(-0.00%)
Market Cap$3315
P/E Ratio
52W High$0.0001
52W Low$0.0001

NewCardio, Inc. (NWCI) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

nwci · pe ratio · data through Dec 31, 2010

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for NewCardio, Inc. (NWCI) measures how much investors pay for each dollar of the company's trailing earnings. NWCI's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.40.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2010-12-31

Forward P/E
N/A
EPS (TTM)
-$0.40
TTM · diluted EPS
PEG Ratio
-0.00
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · NewCardio, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2004 – 2010 · Annual
PE Ratio (TTM)
5Y Avg 353.4x
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Devices · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
NewCardio, Inc.
NewCardio, Inc.You
NWCI
$0MN/A-$0.40
New York Health Care, Inc.
New York Health Care, Inc.
BBAL
$0MN/A-$0.03
Lombard Medical, Inc.
Lombard Medical, Inc.
EVARF
$0MN/A-$1.54
FluoroPharma Medical, Inc.
FluoroPharma Medical, Inc.
FPMI
$0MN/A-$0.06
Caliber Imaging & Diagnostics, Inc.
Caliber Imaging & Diagnostics, Inc.
LCDX
$0MN/A-$0.65
Longport, Inc.
Longport, Inc.
LPTI
$0MN/A
Nemaura Medical Inc.
Nemaura Medical Inc.
NMRD
$0MN/A-$0.57

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 7 of 7 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2010-12-31Latest
FY2010
$-0.40
2009-12-31
FY2009
$-0.40
2008-12-31
FY2008
$-0.68
2007-12-31
FY2007
$-0.85
2006-12-31
FY2006
$-0.00
2005-12-31
FY2005
353.36x$0.00
2004-12-31
FY2004
$-0.00

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for NewCardio, Inc. (NWCI) measures how much investors pay for each dollar of the company's trailing earnings. NWCI's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.40.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.00 ÷ -$0.40 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

NWCI pe ratio · 6 questions

NWCI's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.40. Data sourced from Financial Modeling Prep via NWCI's SEC 10-K and 10-Q filings.

NWCI PE ratioWhat is NWCI PE ratioCurrent PE ratio of NWCINWCI PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · NewCardio, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09